According to reports, the Supreme Court flagged concerns over the wide gap between the price-to-retailer and maximum retail price of essential medicines.
Supreme Court says the forensic audit must remain confined to transactions involving Fortis Healthcare, its holding company, judgment debtors and concerned banks
Malaysia-based IHH Healthcare has announced plans to hike its stake in Fortis Healthcare to 51 per cent over the next three to five years and expand total capacity to around 10,000 beds by 2031. The statement follows the Supreme Court's decision on September 25, 2026, disposing of Fortis Healthcare's special leave petition (SLP) that challenged a Delhi High Court order requiring a forensic audit and certain observations made concerning the company. As per a BSE filing by Fortis Healthcare, an IHH statement said that it will "fully cooperate with the forensic audit" and expressed confidence that an independent review will objectively establish the facts surrounding its 2018 investment. Reaffirming its long-term commitment to the Indian market, IHH said it intends to deepen its footprint and ramp up investments. "Over the next three to five years, we plan to increase our stake in Fortis to 51 per cent, further integrate our Fortis and Gleneagles platforms, and expand our capacity to
Fortis Healthcare had filed a petition against an order that directed the appointment of a forensic auditor into alleged asset dissipation by former promoters, or controlling shareholders, of Fortis
The Supreme Court said the forensic audit must be conducted independently and clarified that the Delhi High Court's observations against Fortis were only tentative
For hospital operators, a Jefferies note said the MPD introduces several measures that could improve asset productivity and enable higher capacity creation in land-constrained areas.
HSBC had earlier upgraded Indian equities to "Neutral" from "Underweight" and raised its 2026-end target for the BSE Sensex index to 84,000 levels.
Fortis Healthcare's board has approved the reappointment of Ashutosh Raghuvanshi as Managing Director for two years from March 19, 2027, subject to shareholder approval
Malaysia's IHH Healthcare plans to expand technology investments in India through Fortis, focusing on AI, precision medicine, advanced oncology and healthtech startups
The agreement marks Fortis Healthcare's first major presence in Odisha
The statement came after Delhi Chief Minister Rekha Gupta directed the District Administration to conduct an immediate inspection of Fortis Hospital in Shalimar Bagh following a complaint received
Nishchal Jain of Share.Market believes that the 'Golden Crossover' suggests the beginning of a multi-quarter recovery cycle for Fortis Healthcare, Deepak Fertilisers and Deepak Nitrite.
Analysts say that the market is rewarding hospital companies not merely as defensive plays, but as scalable consumption businesses with strong pricing power, rising cash flows & long growth visibility
New NBCS 2026 norms remove 45-metre cap on hospital buildings, enabling vertical expansion, lowering capex and reducing reliance on greenfield projects, say industry executives
Equirus Securities reckon that healthcare sector delivered a 15.5 per cent revenue CAGR and a 25 per cent Ebitda CAGR between FY20 and FY25
Fortis Healthcare Ltd on Saturday said its arm Fortis Hospitals Ltd has received a demand notice of Rs 117.04 crore from the income tax authority. Fortis Hospitals Ltd is in receipt of an income tax order dated March 27, 2026, for AY 2024-25 and a demand of Rs 117.04 crore has been raised, it said in a regulatory filing. The company is evaluating all options, including filing an appeal and rectification application against the said order, it added.
Stocks to Watch today, Feb 16: From Ola Electric to Inox Green Energy, here are few stocks that will be on investors' radar
Apollo Hospitals Enterprise has surged 6 per cent to ₹7,640 after the company's hospitals business maintained a strong profitability in Q3FY26.
IHH Healthcare and Fortis Healthcare have launched IHH Catalyst, a national platform to help execution-ready medtech and healthtech startups move from pilots to hospital adoption and scale
JM Financial has set a target price of ₹1,093 on Fortis Healthcare stock, a potential upside of 22.7 per cent from Friday's closing price